GENERAL COMMENTS
This manuscript reports on the study protocol for a randomized control trial testing the impact of the Partners for Change Outcome Management System (PCOMS) on mental health treatment outcomes for adults receiving brief therapy in four settings in The Netherlands. In addition, the authors pose questions to explore under what conditions the PCOMS is effective, including therapist, client, and treatment variables. This is an important study that has the potential to add to the field's understanding of measurement based care (MBC). As MBC becomes more prevalent across countries, it is vital to understand the conditions under which it is most effective.
Some suggestions for revision are as follows: 1) To improve the overall quality of the manuscript, the authors are encouraged to embark on a thorough editing of the manuscript, addressing issues of sentence construction (e.g., run-on or fragment), grammar, and awkward wording.
2) While some of the organization seems driven by the type of manuscript (i.e., a study protocol), in several places there was redundancy of information and/or information seemed like it could have been more appropriately placed elsewhere. As one example, the information on using fixed effects was presented on p. 22 and on p. 13. As another example, the results of the pre-study comparison of sites using the KKL was presented in the Statistical Analysis section, although the relevance there seemed unclear to this reviewer. Instead, it seemed more relevant to include in the section on p. 20 when it was first introduced.
3) The abstract leaves out some information about outcome measures (e.g., the MHC-SF, CQI). In addition, the site level clustering is not mentioned in the description of the multi-level analysis. Further, the analyses of therapist factors is not mentioned.
4) On p. 6, the authors have a section establishing the problem of focusing on groups of patients. First, there appear to be practice guidelines that do specifically address tailoring of treatment for individual patients (e.g., the Ehrenreich's Unified Protocol, Chorpita's MATCH protocol). Second, while the therapeutic alliance is defined, there is a lack of information on the relevance of TA to outcomes. The case could be strengthened by adding more information to this section. 5) On p. 7, last paragraph, the evidence presented appears quite mixed and not consistent with the opening sentences. Rather than a list of studies, it would be useful to have a clear storyline here. 6) On p. 8, lines 16-20 -it would be helpful to have the clinical range for the PCOMS in mind as a benchmark to better understand the information as presented. 7) On p. 8, line 36 -what was the variation across therapists per Anker et als. study? 8) The authors reference the "development of the OQ-45 growth curves" at least twice, but it was not operationalized enough to understand what this term means. 9) p. 10, lines 48-52 seems like a good place to establish the lack of differences among sites. Information and results presented later could be effectively moved here. 10) Relevant to recruitment, was there any attempt to use existing data to establish comparability of the 4 study sites with the overall Mindfit organization? It seems that the data are available -it would be helpful to better understand the limitations of the study by understanding if these self-selected sites were somehow different than others. This should also be listed as a limitation in addition to the small number of sites. 11) p. 13 could benefit from separating concepts (i.e., eligibility, power) into separate sections and/or paragraphs. 12) On p. 13, bottom half, the awareness and modification of the statistical analysis due to the small number of centers was well done. However, instead of referencing equations or models by sections, it would be helpful to use meaningful names or statistical terms. Also, it was unclear why this information was presented in a section titled "randomization procedure." 13) For the intervention section, what computing device is the patient using? A tablet, smartphone, desktop computer? Are there any implementation issues foreseen with lack of access to such devices or to the internet connectivity needed? 14) p.14, lines 54-56 -the meaning of this sentence is unclear 15) p. 16, lines 3-7 -who are the other team members? How is the lack of change communicated? Is it up to the therapist to alert others or is there an automatic alert? The potential for lack of implementation of this aspect of the intervention seems high. 16) p. 16, lines 20-21 -what does supervision consist of? 17) For the analysis of therapist variables, it is unclear how that fits into the larger analytic scheme. One would make the assumption that the intent-to-treat analysis would occur, based on randomization. Then post-hoc analyses would explore the effect of covariates such as these. Further explanation would be helpful.
18) It could be appropriate to describe all the measures in a measures section including use in the study, psychometric properties, and frequency of administration. 19) Given the importance of the discharge assessment to the analysis plan -are there are any concerns about collecting such information at discharge? In other words, clients discharge before measures can be administered.
20) It could be helpful to have a specific section on fidelity of PCOMS -being clear in the definition of fidelity (completed ORS and SRS) and what is not being directly measured (the therapistled aspects of the intervention). The addition of the qualitative study to address these implementation aspects is a strength of the study.
REVIEWER miranda wolpert UCL, UK REVIEW RETURNED
09-Sep-2018
GENERAL COMMENTS
I think this is an important and worthwhile area of research of interest to the field and I found the manuscript clear and well written. There are two main issues which to my mind meed to be addressed and require others' expertise. 1) with the small number of centre's involved and the anticipated small effect size I would want specialist statistical review of whether the authors can address the questions they set themselves 2) the paper references the start of the data collection as 2016 but I had understood protocols needed to be submitted prior to data collection, Perhaps I have misunderstood and the relevant deadline is in relation to data analysis only. I raise for editor view on this aspect. 2. Throughout the manuscript there is an explicit focus on functioning as the treatment target with the PCOMS method and the other outcomes. This is problematic on a number of levels -all of the outcomes cited assess constructs clearly different to functioning (e.g. overall wellbeing on the ORS; Symptomatic distress on the OQ-45, emotional wellbeing on the MHC-SF). This leads to two required revisions -I think that the point you are trying to make is that these measure are associated with an approach that aims to enhance positive mental health and relationships with less focus on trying to get rid of negative aspects. So overall focusing on positive mental health within treatment and its measurement. However, the problematic focus on functioning is obscuring this. If you wish to remain focused on functioning a clear explanation and justification for the obvious contradictions apparent in all of the measures you have used must be given. Secondly, by saying that you are focusing on functioning (when that doesn't seem the sole focus) you have not justified clearly enough why disorder-specific outcomes were not used. This can be more clearly stated in line with the positive mental health conceptualisation. 3. The role of the OQ-45 is unclear in the study and must be clarified for readers to be able to assess its quality. Firstly, it should be made clearer to the reader whether anyone in either arm has been using the OQ-45 in the recommended way -i.e. similar to PCOMS and using it to guide their session content and flag "off-track" cases either prior to the study or during it. If any restrictions on its use in this way are made this should be made clear. Secondly, clarity is required on the way in which it will be used during sessions where it is the key assessment instead of the ORS/SRS -e.g. will therapists get outcome feedback during that session? Will they have access to the clinical support tools associated with the OQ-45? This has the potential to be an important confounding factor as TAU will be getting outcome feedback -we need to know if at risk cases will be flagged and if they will receive information to support change. 4. The lack of any apparent fidelity assessment is regrettable given that at least part of therapist differences may relate to effective use of the PCOMS system. If it will be addressed in supervision this is not described and it is unclear how it would work.
REVIEWER
Specific issues are outlined below. P8 line 10 -The ORS specifically asks about wellbeing rather than functioning on two of its four scales. This description does not adequately cover this element nor does the preceding explanation. P11 line 30 one and a half days P12 line 15 an overview reference for each of these approaches would be helpful. P14 line 22 as part of treatment as usual P14 line 43 A common approach P15 line 30 -perhaps not here but it would be helpful to be clear whether this number is achievable given the flow of clients at each center, perhaps using data from the year prior to the trial starting. P15 line 30 -Further information about the centers would be helpful here. In particular how they compare on waiting times -this is an important variable affecting outcome especially when there are only four centers. P15 line 41. It is not accurate to suggest that the ORS is purely assessing functioning as it clearly states that it is asking about personal wellbeing and overall wellbeing not functioning P16 line 18 There needs to be an explanation of the signalling system here so that readers can understand that "off-track cases will be signalled to therapists". This is particularly relevant given the importance of this component in previous research. P17 line 20 You variably state supervision will be offered every six weeks/ four to six weeks -given that regular supervision of offtrack cases is a central part of outcome feedback methods it would be helpful to be consistent. P20 line 43 -Would this mean that the OQ 45 is administered by the treating therapist and given growth curve feedback? If so this would be a significant contaminator of the outcome feedback approach and should be more strongly stated here. Are we clear that the TAU group will not be using the OQ-45 for outcome feedback and monitoring if it is part of routine outcome monitoring? This must be taken into account, as it could lead to a great underestimate of the impact of PCOMS if both arms have outcome feedback systems in place. P21 line 56 Therapists with high self-efficacy have more belief 

Sarah Barry University of Strathclyde, UK REVIEW RETURNED
04-Oct-2018
GENERAL COMMENTS
This is an interesting study but it requires some more detail in several areas.
Can the authors confirm whether or not data collection is complete? The protocol states that 'Over a period of two years, all included patients will be followed, starting in January 2016'. This would suggest that all patients should have been recruited by now and that it is possible that all would have completed the study.
Abstract: this is a randomised controlled trial, not a cohort study. Also, the second sentence of the methods and analysis section should say that 'Two centers will be randomised to…' rather than 'participate in'.
Page 12: please give a little more detail on the Mindfit organisation, for international readers who may not be familiar with it.
Page 11: 'all centers have between eight or ten employees' should say 'all centers have between eight and ten employees'. I think also it would be more useful to know the number of therapists than total employees. The inclusion and exclusion criteria should be explicitly stated in a section of the protocol.
I think the paragraph under Table 1 (with the exception of the mention of the inclusion criteria) should be under the heading 'Sample size calculation'.
Primary and secondary outcomes should be explicitly stated in a section of the protocol.
The control therapy should be detailed in a section.
Why was the KKL used to assess the treatment effect prior to the study, rather than the outcomes that were actually going to be used in the study?
In several places the authors state that the primary outcome is the development of the OQ-45 growth curves. However, the statistical analysis section is not clear on how they will be compared. Growth curves would suggest the whole curve (or some summary of it, such as the area underneath it) is going to be compared between intervention and control patients, but the authors do not say how they are going to do this.
The number of sessions is being included in the modelling as a covariate. However, I would imagine that this would be an important outcome in its own right, since if PCOMS reduces the number of sessions required to reach a satisfactory outcome, then that would be of benefit to both patients and therapists and would cost less.
The authors state that 'A treatment will be included when it covers at least three sessions with PCOMS.' Does this mean that they will only include the data for a particular patient if they have at least three sessions with PCOMS? Or that they will only recruit the patient to the study if three sessions are planned? The authors need to be clear about what this means and the implications for the generalisability of the results of the study. I would be concerned if they are planning to exclude data from a recruited patient who received fewer than 3 sessions. I can accept a sensitivity analysis being done on this basis, but the main final analysis set of patients for the study should include all of those recruited.
Some typos: Bottom of page 6: 'originally OQ-45' should say 'original OQ-45'. Page 10, line 30: 'one and a half day' should say 'one and a half days'. Randomization procedure: 'An independent researcher not involved in the study warranted randomization' -the word 'warranted' is not appropriate here. The authors may mean 'performed the' or 'carried out the' instead. Bottom of Page 19: 'In the BT-PCOMS condition therapists are given specific criteria on when to handle when there is no progress.' -I think this should say '…how to handle…'. Bottom of page 20: 'Therapists with high self-efficacy have more believe' should say 'Therapists with high self-efficacy have more belief'. The authors should ensure that acronyms are expanded on their first mention; eg. CBT, ROM. This manuscript reports on the study protocol for a randomized control trial testing the impact of the Partners for Change Outcome Management System (PCOMS) on mental health treatment outcomes for adults receiving brief therapy in four settings in The Netherlands. In addition, the authors pose questions to explore under what conditions the PCOMS is effective, including therapist, client, and treatment variables. This is an important study that has the potential to add to the field's understanding of measurement based care (MBC). As MBC becomes more prevalent across countries, it is vital to understand the conditions under which it is most effective.
VERSION 1 -AUTHOR RESPONSE
Some suggestions for revision are as follows:
1) To improve the overall quality of the manuscript, the authors are encouraged to embark on a thorough editing of the manuscript, addressing issues of sentence construction (e.g., run-on or fragment), grammar, and awkward wording.
--
We thoroughly reedited the manuscript, addressing the mentioned issues. We used more commas and semicolons, and used more coordinating or subordinating conjunctions to correct for run-on sentences. In sentence fragments, we included the missing element and also used the textual suggestions made by the other reviewers.
--We agree that some information is too widespread throughout the manuscript. We therefore deleted several sentences and also made changes throughout the whole document, clustering information, and making it less redundant. The information about the centers is now clustered under the section 'Recruitment' and the order of table 1 and 2 is reversed. The information on using fixed effects is now clustered under the section 'Statistical analysis'.
--Due to the small number of participating centers, a fixed effects regression is used to correct for the site level clustering. This is why it is not mentioned in the description of the multi-level analysis.
The analysis of the therapist factors is added. The MHC-SF and the CQI are now mentioned, as well as the structured interviews.
4) On p. 6, the authors have a section establishing the problem of focusing on groups of patients. First, there appear to be practice guidelines that do specifically address tailoring of treatment for individual patients (e.g., the Ehrenreich's Unified Protocol, Chorpita's MATCH protocol). Second, while the therapeutic alliance is defined, there is a lack of information on the relevance of TA to outcomes. The case could be strengthened by adding more information to this section. We also added some more information adding 'having a robust effect on treatment outcome of approximately 7 % throughout different kinds of therapies.' to the sentence 'Apart from creating tailor made treatment, the effectiveness of therapy also depends on the quality of the working alliance'. This is a small addition to ensure that the background section is not too long.
5) On p. 7, last paragraph, the evidence presented appears quite mixed and not consistent with the opening sentences. Rather than a list of studies, it would be useful to have a clear storyline here.
We rewrote the whole section 'PCOMS, combining Randomised Control Trials with a Clinical
Reasoning Tool' and added a more clear storyline.
6) On p. 8, lines 16-20 -it would be helpful to have the clinical range for the PCOMS in mind as a benchmark to better understand the information as presented.
--
The paragraph is rephrased and the ORS clinical cutoff score of 25 is added.
7) On p. 8, line 36 -what was the variation across therapists per Anker et als. study? --
The exact variation is not mentioned. Therapists at the lower end of effectiveness benefited more from feedback than their more successful colleagues. This is now added in the manuscript.
8) The authors reference the "development of the OQ-45 growth curves" at least twice, but it was not operationalized enough to understand what this term means.
--
The authors agree that this is a confusing reference. Throughout the manuscript the sentence 'The primary outcome measure is the development of the Outcome Questionnaire (OQ-45) growth curves, across time, across conditions.' has been rephrased into 'The primary outcome measure is the Outcome Questionnaire (OQ-45).' 9) p. 10, lines 48-52 seems like a good place to establish the lack of differences among sites. Information and results presented later could be effectively moved here.
--We agree that the information about the participating centers is too widespread throughout the manuscript. We deleted the sentence 'Before the study started background variables of therapists within the participating mental health centers were contrasted to test a priori comparability.' and the section 'Participating centers'. The information about the centers is now clustered under the section 'Recruitment' and the order of table 1 and 2 is reversed.
10) Relevant to recruitment, was there any attempt to use existing data to establish comparability of the 4 study sites with the overall Mindfit organization? It seems that the data are available -it would be helpful to better understand the limitations of the study by understanding if these self-selected sites were somehow different than others. This should also be listed as a limitation in addition to the small number of sites.
--This is an excellent addition. The data were indeed available and we found no differences between the four participating centers and the overall Mindfit organization. We added this information in the section recruitment and in table 1.
11) p. 13 could benefit from separating concepts (i.e., eligibility, power) into separate sections and/or paragraphs.
We added an extra section called 'Sample size calculation'.
12) On p. 13, bottom half, the awareness and modification of the statistical analysis due to the small number of centers was well done. However, instead of referencing equations or models by sections, it would be helpful to use meaningful names or statistical terms. Also, it was unclear why this information was presented in a section titled "randomization procedure."
We added an extra section called 'Sample size calculation' and presented the information there. We also rephrased this section into more meaningful names and terms.
13) For the intervention section, what computing device is the patient using? A tablet, smartphone, desktop computer? Are there any implementation issues foreseen with lack of access to such devices or to the internet connectivity needed?
--We agree that this is an important issue. All patients are using the therapist's desktop computer or laptop. Mindfit has an excellent office automation service guaranteeing almost 100 % device access and internet connectivity. This is added in the manuscript.
14) p.14, lines 54-56 -the meaning of this sentence is unclear --
The sentence is indeed confusing and is deleted.
15) p. 16, lines 3-7 -who are the other team members? How is the lack of change communicated? Is it up to the therapist to alert others or is there an automatic alert? The potential for lack of implementation of this aspect of the intervention seems high.
--All team members are therapists. The word 'team members' has therefore been replaced by 'therapists'. All patients receive individual therapy, so lack of change is directly visible and discussed with the patient by the treating therapist, therefore not leading to a lack of implementation. The lack of change is also shown at the results with a red arrow pointing down.
16) p. 16, lines 20-21 -what does supervision consist of?
--Supervision consists of a one hour supervision-session with all team members, where therapists are given the opportunity to review their work with patients. In the BT-PCOMS condition therapists are encouraged to also show the the score patterns of the ORS and SRS over time so these can be discussed too. This is added in the manuscript.
17) For the analysis of therapist variables, it is unclear how that fits into the larger analytic scheme. One would make the assumption that the intent-to-treat analysis would occur, based on randomization. Then post-hoc analyses would explore the effect of covariates such as these. Further explanation would be helpful.
--In our therapist factors part of this study we decided, based on the feedback of the reviewers, to include all intention to treat patients to examine whether therapist factors have an impact on properly conducting PCOMS. We added this in our 'Therapists characteristics Study' section.
18) It could be appropriate to describe all the measures in a measures section including use in the study, psychometric properties, and frequency of administration.
--This can be found in the section called 'Measurements' in the manuscript.
19) Given the importance of the discharge assessment to the analysis plan -are there are any concerns about collecting such information at discharge? In other words, clients discharge before measures can be administered.
--There are some concerns of the discharge assessment. Patients receive an email with a link to their final assessment to remind them. Furthermore, the number of patients treated by each center doubles the number of patients needed according to our sample size calculation so we have room for error.
20) It could be helpful to have a specific section on fidelity of PCOMS -being clear in the definition of fidelity (completed ORS and SRS) and what is not being directly measured (the therapist -led aspects of the intervention). The addition of the qualitative study to address these implementation aspects is a strength of the study.
--
We added the sentence 'In this study, fidelity will be defined as having completed at least three full sessions with PCOMS.' in the 'training and adherence' section. There are two main issues which to my mind meed to be addressed and require others' expertise.
1) with the small number of centre's involved and the anticipated small effect size I would want specialist statistical review of whether the authors can address the questions they set themselves --
We agree that this study requires specialist statistical expertise. That is why we asked Mirjam Moerbeek, an expert on multi-level analysis (see https://www.uu.nl/staff/MMoerbeek), to provide us the necessary statistical knowledge. She is one of the co-authors of this manuscript.
2) the paper references the start of the data collection as 2016 but I had understood protocols needed to be submitted prior to data collection, Perhaps I have misunderstood and the relevant deadline is in relation to data analysis only. I raise for editor view on this aspect.
The submission guidelines of BMJ Open state: 'Protocol papers should report planned or ongoing studies.' This study is an ongoing study, data will be included till July 1, 2019.
Reviewer: 3
Reviewer Name: Sam Malins Institution and Country: University of Nottingham, UK Please state any competing interests or state 'None declared': None declared This manuscript describes a study which can make a useful contribution to the field of outcome feedback and monitoring in psychological therapies.
Key strengths are:
1. It is timely following a large scale trial of outcome feedback recently published in Lancet psychiatry identifying 11% therapist effect on the impact of outcome feedback -this study will help clarify some of the key contributors to therapist effects. It therefore fits a key gap in outcome feedback and monitoring literature.
2. In particular the therapist level factors are well chosen and emergent from appropriate, relevant literature. A better understanding of the impact these factors have will be helpful to therapists, clients and those who manage and commission such services.
3. Really good that the opportunity to change therapist is included as a treatment option from outcome feedback, this is an important and under-researched means of responsiveness when clients do not improve from therapy Key limitations are:
1. The background section opens very broadly on diagnostic categorization and its problems to situate the interested reader, but probably takes too long to focus in on the key current issues in outcome feedback and monitoring.
We deleted some sentences in the background section but also added some text based on remarks of other reviewers. In general the background section is now more coherent and more focused on outcome feedback and monitoring.
They also do not pick up on recent recommendations made by leaders in this field -particularly no reference is made to a 2015 special issue of Psychotherapy dedicated to the topic. Indeed some issues identified by the developers of PCOMS are not addressed (Miller et al., 2015 -Beyond Measures and Monitoring: Realising the Potential of Feedback-Informed Treatment).
We agree and made a reference to this manuscript in our section 'Therapist characteristics Study'.
Lastly, a brief critique of the ORS and SRS psychometrics in relation to the OQ-45 would be helpful.
--This is added in the 'Measurements' section; The correlation between the Dutch ORS total scale and the OQ-45 is -0.62.
2. Throughout the manuscript there is an explicit focus on functioning as the treatment target with the PCOMS method and the other outcomes. This is problematic on a number of levels -all of the outcomes cited assess constructs clearly different to functioning (e.g. overall wellbeing on the ORS; Symptomatic distress on the OQ-45, emotional wellbeing on the MHC-SF). This leads to two required revisions -I think that the point you are trying to make is that these measure are associated with an approach that aims to enhance positive mental health and relationships with less focus on trying to get rid of negative aspects. So overall focusing on positive mental health within treatment and its measurement. However, the problematic focus on functioning is obscuring this. If you wish to remain focused on functioning a clear explanation and justification for the obvious contradictions apparent in all of the measures you have used must be given.
Secondly, by saying that you are focusing on functioning (when that doesn't seem the sole focus) you have not justified clearly enough why disorder-specific outcomes were not used. This can be more clearly stated in line with the positive mental health conceptualisation.
--We agree and rewrote the whole manuscript changing its focus on positive mental health instead of on functioning.
3. The role of the OQ-45 is unclear in the study and must be clarified for readers to be able to assess its quality. Firstly, it should be made clearer to the reader whether anyone in either arm has been using the OQ-45 in the recommended way -i.e. similar to PCOMS and using it to guide their session content and flag "off-track" cases either prior to the study or during it. If any restrictions on its use in this way are made this should be made clear.
Secondly, clarity is required on the way in which it will be used during sessions where it is the key assessment instead of the ORS/SRS -e.g. will therapists get outcome feedback during that session? Will they have access to the clinical support tools associated with the OQ-45? This has the potential to be an important confounding factor as TAU will be getting outcome feedback -we need to know if at risk cases will be flagged and if they will receive information to support change.
--Primary purpose of ROM in the Netherlands, is a collection of treatment data for all patients in Dutch mental healthcare, therefore more being used as an outcome measurement instrument for benchmarking than a process monitoring instrument. The use of the OQ-45 and MHC-SF is not accompanied with clinical support tools. Since ROM is mandatory used in both conditions, but primarily for benchmark purposes, it will be a small confounder. This information is now added in the 'Measurements' section.
4. The lack of any apparent fidelity assessment is regrettable given that at least part of therapist differences may relate to effective use of the PCOMS system. If it will be addressed in supervision this is not described and it is unclear how it would work.
--Supervision consists of a one hour supervision-session with all team members, where therapists are given the opportunity to review their work with patients. In the BT-PCOMS condition therapists are encouraged to also show the the score patterns of the ORS and SRS over time so these can be discussed too. This is added in the manuscript in the 'Adherence' section.
Specific issues are outlined below.
P8 line 10 -The ORS specifically asks about wellbeing rather than functioning on two of its four scales. This description does not adequately cover this element nor does the preceding explanation.
--We agree. The word 'functioning' has been replaced by 'wellbeing'.
P11 line 30 one and a half days --
The fragment 'one and a half day' has been altered to 'one and a half days'.
P12 line 15 an overview reference for each of these approaches would be helpful. The word 'A' is added.
P15 line 30 -perhaps not here but it would be helpful to be clear whether this number is achievable given the flow of clients at each center, perhaps using data from the year prior to the trial starting.
--This number seems achievable, 208 patients is approximately 50 % of the total patients each center will treat in this period. This is added in this section.
P15 line 30 -Further information about the centers would be helpful here. In particular how they compare on waiting times -this is an important variable affecting outcome especially when there are only four centers.
--All centers have no waiting list. This is added in the text.
P15 line 41. It is not accurate to suggest that the ORS is purely assessing functioning as it clearly states that it is asking about personal wellbeing and overall wellbeing not functioning --We agree. The word 'functioning' has been replaced by 'wellbeing'.
P16 line 18 There needs to be an explanation of the signalling system here so that readers can understand that "off-track cases will be signalled to therapists". This is particularly relevant given the importance of this component in previous research.
--
The signalling system is explained in the 'Training and adherence' section. In this section we added 'the therapists is signalled'.
P17 line 20 You variably state supervision will be offered every six weeks/ four to six weeks -given that regular supervision of off-track cases is a central part of outcome feedback methods it would be helpful to be consistent.
The sentence is changed into 'four to six weeks'.
P20 line 43 -Would this mean that the OQ 45 is administered by the treating therapist and given growth curve feedback? If so this would be a significant contaminator of the outcome feedback approach and should be more strongly stated here. Are we clear that the TAU group will not be using the OQ-45 for outcome feedback and monitoring if it is part of routine outcome monitoring? This must be taken into account, as it could lead to a great under-estimate of the impact of PCOMS if both arms have outcome feedback systems in place.
The use of ROM is mandatory in the Netherlands, more being used as an outcome measurement instrument for benchmarking than a process monitoring instrument. Therapists can see growth curves of the OQ-45 and MHC-SF but this is not accompanied with clinical support tools. Therapists are not trained in using this ROM to guide their therapy sessions nor to flag Not On Track patients. Since ROM is used by default in both conditions, but primarily for benchmark purposes, it will be a small confounder. This information is now added in the 'Measurements' section.
P21 line 56 Therapists with high self-efficacy have more belief --
The sentence is adjusted accordingly.
Figure 4: It is unclear whether week 5 is the start point for treatment. If so please can it be labelled as such if not please could this be added so it is clear.
--All centers of Mindfit have no waiting list, including the four participating centers, and all patients can start therapy immediately. To clarify this we rephrased the sentence; 'All patients will be assessed four times (see Figure 4) , at the beginning of the therapy, after 5weeks, after 13 weeks and at the end of therapy.' into 'All patients will be assessed four times (see Figure 4) , at the beginning of the therapy, after 5 weeks of therapy, after 13 weeks of therapy and at the end of therapy.' In this section.
Reviewer: 4
Reviewer Name: Sarah Barry Institution and Country: University of Strathclyde, UK Please state any competing interests or state 'None declared': None declared This is an interesting study but it requires some more detail in several areas.
--Data collection is not completed. This study has three parts; 1) Comparing patients receiving TAU with patients receiving TAU + PCOMS 2) PCOMS and therapist factors 3) Structured interviews with patients about their experience of using PCOMS. Part 1 of the data collection is completed, part 2 and 3 are still ongoing. We hoped to finish our data collection on January 1, 2019 but we had some delay and we now expect to include data till July 1, 2019. We changed this date in our manuscript.
--The term 'cohort study' has been changed throughout the whole document into 'clinical study'. The second sentence of the methods and analysis section has been changed accordingly.
--Some extra detail is added in this section.
Page 11: 'all centers have between eight or ten employees' should say 'all centers have between eight and ten employees'. I think also it would be more useful to know the number of therapists than total employees.
The sentence has been altered into 'All centers have between eight and ten therapists'
The inclusion and exclusion criteria should be explicitly stated in a section of the protocol.
We deleted the description of the inclusion criteria in the 'Randomization procedure' section and described the inclusion and exclusion criteria in the 'Methods' section.
We agree and added an extra section.
In the first part of this study, primary outcomes are the OQ-45 and MHC-SF. Secondary outcomes are patient satisfaction, costs, drop-out and duration. This is now stated in the 'Statistical analysis' section.
In the section 'Basic mental health care', we described the approach as based on (positive) cognitive behavioral therapy and solution focused therapy.
